: "evidence for decreased calcitonin gene-related peptide (cgrp) receptors and compromised responsiveness to cgrp of fetoplacental vessels in preeclamptic pregnancies."
.
.
.
international
.
.
.
as of this month, there are 56 companies in china involved in the commercialization of car cell therapies
.
.